Amanote Research
Register
Sign In
Letter: Immunogenicity of Infliximab Originator vs. CT-P13 in IBD Patients-Authors’ Reply
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.14274
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
October 11, 2017
Authors
Y. Komaki
A. Yamada
F. Komaki
A. Sakuraba
Publisher
Wiley